NASDAQFinancialsInsurance - BrokersSnapshot 2026-08-31
Reading LIFE? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Warn: Primary pillar under pressure — Improve adjusted EBITDA to $103M-$107M for 2026: FY26 adj EBITDA guided $119M-$123M vs $103M-$107M target.
Ethos aims to reach $563M revenue in 2026. It targets adjusted EBITDA near $105M. The company is addressing recent earnings misses. The stock trades below Street targets, offering potential upside.
Ethos missed earnings recently and faces investor doubts. Profitability remains weak with a net loss in Q1. The stock is under pressure amid a selloff and short reports.
The price is about 14% above our fair value near $17. Our fair value is 37% below the Street median of $27, reflecting skepticism on Ethos's turnaround.
Breaks if: annual revenue falls below $561M in FY26
Continue driving strong revenue growth to meet or exceed full-year 2026 revenue guidance.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story with a medium confidence level. LIFE is working to improve its financial metrics while navigating a sector that has a favorable backdrop.
The market currently reflects a premium valuation compared to peers, indicating that expectations are somewhat high. However, there is a noted expectations gap, suggesting that the market may not fully account for recent weak performance.
Management is on track to achieve revenue and adjusted EBITDA guidance for 2026, showing some positive momentum. However, recent financial performance has been weak, which could pose risks in the near term.
The thesis hinges on whether LIFE can maintain its revenue and profitability targets while the broader Financials sector continues to perform well. Any negative guidance or earnings misses from sector bellwethers could impact LIFE's trajectory.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats impacting the thesis at this time.
as of 2026-08-31
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 2 of last 2 quarters. Revenue grew 113% year-over-year to $189.6 million in 2026-Q2 from $88.8 million in 2025-Q2. Full year 2026 revenue guidance increased from $561-$565 million in Q1 to $727-$731 million in Q2, reflecting management's upward revision and delivering strong growth.
“For the full fiscal year 2026, Ethos expects total revenue between $727 million and $731 million.”
“For the full fiscal year 2026, Ethos expects total revenue between $561 million and $565 million.”
Breaks if: earnings continue to miss guidance in next 2 quarters
Ethos is addressing the earnings miss reported in the recent quarter.
Breaks if: adjusted EBITDA falls below $103M in FY26
Ethos aims to improve its adjusted EBITDA to between $103M and $107M for fiscal year 2026.
Over the next 1 to 3 years, LIFE's performance will depend on management's execution and sector dynamics. Not investment advice.
